Showing 1491-1500 of 3134 results for "".
- AAD 2026: Lumenis Launches triLIFT 2.0 for Combined Muscle and Skin Rejuvenationhttps://modernaesthetics.com/news/lumenis-launches-trilift-20-for-combined-muscle-and-skin-rejuvenation/2486430/Lumenis Be Ltd. announced the commercial launch of triLIFT 2.0, a next-generation platform designed to deliver combined muscle stimulation and skin rejuvenation for facial and body applications. The system integrates Dynamic Muscle Stimulation technology (DMSt) with FibroBoost, aiming to address
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- Lynch Regenerative Medicine Expands PDGF Portfolio With GEM 21S® Distribution Agreementhttps://modernaesthetics.com/news/lynch-regenerative-medicine-expands-pdgf-portfolio-with-gem-21s-distribution-agreement/2486379/Lynch Regenerative Medicine, LLC (LRM) announced a definitive distribution agreement with Lynch Biologics, a Geistlich North America company, to commercialize GEM 21S®, an FDA-approved recombinant human platelet-derived growth factor (rhPDGF-BB) product, to licensed healthcare providers in the Un
- New Hydrobiome Serum Targets Skin Barrier and Microbiome Balancehttps://modernaesthetics.com/news/new-hydrobiome-serum-targets-skin-barrier-and-microbiome-balance/2486308/Epicutis has announced the launch of Hydrobiome Serum, a new addition to its clinical skincare portfolio developed in partnership with Signum Biosciences. The formulation is designed for patients with blemish-prone or congested skin and emphasizes microbiome balance and barrier support rather tha
- Survey Data Shows Growth in Male Facial Plastic Surgery Patientshttps://modernaesthetics.com/news/survey-data-shows-growth-in-male-facial-plastic-surgery-patients/2486041/New survey data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) suggest continued growth in the number of men seeking facial cosmetic procedures. According to the organization’s 2025 survey, 95% of facial plastic surgeons reported tr
- Internal Mammary Vessels Lead in Autologous Breast Reconstruction, Review Findshttps://modernaesthetics.com/news/internal-mammary-vessels-lead-in-autologous-breast-reconstruction-review-finds/2485836/Autologous breast reconstruction most commonly relies on free tissue transfer to achieve natural-appearing and aesthetically favorable outcomes. In a narrative review published in Gland Surgery, the authors examined recipient vessel selection strategies and their clinical implications in
- WiQo US Expands Midwest Footprint Through Exclusive Partnership With Synergy Aestheticshttps://modernaesthetics.com/news/wiqo-us-expands-midwest-footprint-through-exclusive-partnership-with-synergy-aesthetics/2485815/WiQo US announced a strategic partnership with Synergy Aesthetics, granting the organization exclusive rights to represent the WiQo PRX product system across a 10-state Midwest region. The agreement covers Arkansas, Iowa, Kansas, Minnesota, Missouri, Nebraska, Nort
- PRP Accelerates Hair Regrowth in Murine Model, Study Findshttps://modernaesthetics.com/news/prp-accelerates-hair-regrowth-in-murine-model-study-finds/2485767/Subcutaneous platelet-rich plasma (PRP) injections accelerated hair regrowth and increased Wnt10b expression in a murine model, according to a study published in Aesthetic Plastic Surgery. Investigators led by Guangyu Mao evaluated the effects of PRP on hair follicle cycling in 20
- Lynch Regenerative Medicine Names General Counsel, CMOhttps://modernaesthetics.com/news/lynch-regenerative-medicine-names-general-counsel-cmo/2485740/Lynch Regenerative Medicine (LRM), a regenerative medicine company focused on platelet-derived growth factor–based therapies, has named Madison Dini as General Counsel and Chad Lindemann as Chief Marketing Officer. According to the company, Dini will lead legal, compliance, and corporate g
- Merz Aesthetics Marks 15 Years of XEOMIN® With New National Campaignhttps://modernaesthetics.com/news/merz-aesthetics-marks-15-years-of-xeomin-with-new-national-campaign/2485650/Merz Aesthetics is commemorating 15 years since the US Food and Drug Administration (FDA) approved XEOMIN® (incobotulinumtoxinA) for aesthetic use, marking a milestone for the company’s flagship neurotoxin in the competitive US injectable market. Approved f